Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Traction, Pressure, and Rapid Muscle Release (TPR) during a vitamin B12 injection

Official title: The Effect of the Traction, Pressure, and Rapid Muscle Release (TPR) Technique on Pain and PatientSatisfaction During Intramuscular Injection: A Randomized Controlled Experimental Study

Run by Bezmialem Vakif University · NCT07499687 · Data updated 2026-11-12

This study tests whether the TPR technique used during intramuscular vitamin B12 injections reduces pain and improves patient satisfaction compared with the conventional injection method.

More Patient Satisfaction trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment102 (estimated)
SponsorBezmialem Vakif University
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedApril 6, 2026
Main results expectedJuly 10, 2026
Study endsNovember 2026
Registry record updatedOctober 8, 2026
Trial IDNCT07499687 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 years old, Turkish-speaking, with BMI 18.5–30, and no ventrogluteal sensory impairment, who consent to participate.

Probably not a fit

Individuals with injection-related fear, recent ventrogluteal injections, diabetes, neuropathy, or recent analgesic use before the procedure may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will compare the Traction, Pressure, and Rapid Muscle Release (TPR) technique to standard intramuscular injection in adults receiving vitamin B12. The aim is to see if TPR can lessen pain and increase satisfaction during the injection process. Eligible participants are Turkish-speaking adults aged 18 to 65 with BMI 18.5–30 and no ventrogluteal sensory impairment. Exclusion criteria include recent injection-site issues, prior injection-related fear, and several medical conditions or concurrent analgesic use. The study is led by Bezmialem Vakif University with a site at Başakşehir Çam and Sakura City Hospital Emergency Department in Istanbul, Türkiye.

Why it matters

Potential benefit: If successful, participants may experience less pain and higher satisfaction during intramuscular injections.

How similar studies have gone: Pain-reduction techniques during injections have shown variable benefits; this study tests a novel application of TPR in IM injections.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Voluntary participation in the study
* Ability to speak and understand Turkish
* Being between 18 and 65 years of age
* Having a body mass index (BMI) between 18.5 and 30
* No sensory impairment in the ventrogluteal muscles

Exclusion Criteria:

* Presence of a scar, burn, redness, hematoma, bruising, tenderness, or induration at the injection site
* History of intramuscular injection in the ventrogluteal region within the last 15 days
* Presence of injection-related fear
* Diagnosis of Diabetes Mellitus
* History of neuropathy
* Presence of any hearing, visual, or speech impairment
* Presence of a mental disability
* Use of oral or parenteral analgesic medication before the procedure.

Where it's running

  • Ministry of Health of the Republic of Türkiye Başakşehir Çam And Sakura City Hospital Emergency Department
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.